American depository receipts of European stocks were 0.01% higher at 137.64 on the Bank of New York Mellon Europe ADR Index on Friday morning.
Gainers in Continental Europe were led by Forward Pharma ( FWP ), a Danish biopharmaceutical company, up by 5.1%, Sequans Communications ( SQNS ), a French developer of chipset solutions, 2.7% higher, ERYTECH Pharma ( ERYP ), a France-based biopharmaceutical company, up by 1.9% and Trivago ( TRVG ), operates an online hotel search platform, was up by 1.8%.
In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, up by 2.5%, Midatech Pharma (MTP), up by 1.9% and CRH (CRH), a building materials company, trading 1.3% higher. Prudential (PUK), a financial services group, was up by 1.1%.
Decliners in Continental Europe were led by Cellectis (CLLS), a French genome engineering company, was 2.6% lower, Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, down by 2.3% and telecommunications companies Telecom Italia (TI) and Telecom Italia - Savings (TI.A), 1.6% and 1.4% lower, respectively.
In the UK, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was 1.6% lower, Unilever (UL), a Dutch consumer goods company, was down by 1.2% and GW Pharmaceuticals (GWPH), a biopharmaceutical company, 1.0% lower and GlaxoSmithKline (GSK), a health care company, was 0.8% lower.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.